Article Details
Retrieved on: 2018-01-17 04:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Vanguard Group</b> Inc. grew its holdings in Onconova Therapeutics by 58.4% during the second quarter. <b>Vanguard Group</b> Inc. now owns 87,940 shares of the biopharmaceutical company's stock valued at $190,000 after purchasing an additional 32,418 shares during the period. Hedge funds and ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here